News 21 May 2025 GluGene Therapeutics Secures Initial Financial Investor Participation in Series A Financing Round GluGene Therapeutics, a biotechnology company developing advanced adeno-associated virus (AAV) platform technologies for next-generation gene therapies, announced that participation by… GluGene